CR500

CR500
Product Description

CR500 has been developed to prevent and attenuate the physiological degeneration of cartilage in osteoarthritis, thereby protecting against and slowing the progression of joint damage.  It stands as a game changer for cartilage and joint health because, unlike any existing option in the OA market, the device offers a differentiated, non-invasive approach for cartilage health and joint function improvement.

Read more Show less

Contrad Swiss SA

  • Country/Region:
    Switzerland
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
OTC
Pharmaceutical company
Primary activities
Cosmeceuticals
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Bone & Joint Health
More specifications Fewer specifications

Contrad Swiss SA

  • Country/Region:
    Switzerland
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
OTC
Pharmaceutical company
Primary activities
Cosmeceuticals
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Contrad Swiss SA (2)

  • 500 Line - Orthopaedic topical medical devices

    Product 500 Line - Orthopaedic topical medical devices

    500Line by Contrad Swiss is a cutting-edge solution designed to support the treatment of acute and chronic musculoskeletal (MSK) disorders, integrating the power of SIGMOLECS®, one of the most innovative solutions available for optimal joint and soft tissue wellness. This breakthrough portfolio include...
  • ST500

    Product ST500

    ST500 is intended to limit the physiological degeneration of tendons and ligaments, thereby aiding joint movement. It is the future of tissue regeneration, a unique non-invasive formulation designed to accelerate tissue recovery, setting a new standard in regenerative treatments, with a remarkable impr...